Introduction
Carcinosarcoma is a relatively rare tumor characterized by a mixed composition of malignant epithelial and mesenchymal components with a poor prognosis. This tumor occurs in various anatomic locations such as head and neck, respiratory tract, uterus, ovaries and other sites. Within the digestive tract, it is most often seen in the esophagus. Carcinosarcoma of the colon was first reported by Weidner and Zekan in 1986 [1] , and since then fewer than 20 cases have been reported. In this paper we report a case with carcinosarcoma of the colon found during treatment for hepatic cancer. Carcinosarcoma of the colon is a very rare disease and we discuss it with reference to the literature.
Case Report
The patient was a 65-year-old male presenting with the chief complaints of feeling of oppression in the lower abdomen and diarrhea. He had a past history of hepatitis B, hepatic cell carcinoma and hypertension. His family history was unspecific. Diarrhea occurred from October 2007, and abdominal distention developed from December. The patient had been diagnosed as having colon cancer by the previous doctor. He visited us for surgery and treatment, wished to undergo surgery in our hospital, and so was admitted. His height was 167.3 cm and his weight was 58.0 kg. Nutritional state was slightly poor. Blood pressure was 88/59 mm Hg, pulse rate was 96 bpm and regular, and the bulbar conjunctiva and palpebral conjunctiva were normal. There was no swelling of superficial lymph nodes. The abdomen was swollen and a mass was palpated in the lower abdomen. Findings on admission were: anemia with Hb 10.2 g/dl, CEA 2.3 IU/ml, CA19-9 36.0 ng/ml and AFP 18.0 ng/ml. Barium enema examination showed a mass being compressed from the outside of the wall in the sigmoid colon ( fig. 1) . Colon endoscopy revealed a smooth granulation-like mass with glazed surface projecting within the lumen at about 15 cm from the anal verge ( fig. 2) . The tumor was elastic and soft, and it was difficult to insert the fiber through it to the oral bowel. In an image of the tumor tissue by biopsy, proliferation of atypical cells was observed in part of the degenerated or necrotic tissues, which was diagnosed as undifferentiated cancer. Immunostaining was additionally conducted and was positive for cytokeratin 7 and negative for cytokeratin 20, hepatocyte and AFP. CT revealed a mass of approximately 15 cm within the pelvis whose inside was inhomogeneous and whose boundary was comparatively distinct. Contrast effect was observed on the margins. There were no distinct infiltrations into the other organs ( fig. 3) . MRI also depicted it as a mass with a distinct boundary and inhomogeneous inside. Based on the above findings, surgery was conducted under the diagnosis of undifferentiated cancer of the colon.
Surgical findings showed that the mass originated from the sigmoid colon, and part of it infiltrated the bladder, so part of the bladder was resected together with the mass. Intraoperatively, a small white nodule was observed in part of the greater omentum, which was diagnosed as peritoneal semination by intraoperative rapid diagnosis. None of the 26 extracted lymph nodes developed metastasis, and surgical stage was SiN0H0P1M(-), stage IV according to the General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. The solid cut surface of the lesion showed that the tumor was submucosal and part of it became necrotic with bleeding ( fig. 4) .
The HE finding revealed that atypical epithelial cells had various sizes of duct structure, forming an alveolar structure. Partly spindle-shape atypical cells had proliferated and formed a sarcomatoid shape, but there were no ectopic mesenchymal components of bone, cartilage, and striated muscle. There was a transitional zone, though slightly indistinct, between the epithelial tumor part and mesenchymal tumor part with a component ratio of 9:1 between the former and the latter ( fig. 5) . Immunostaining was positive for cytokeratin 7, negative for cytokeratin 20, partially positive for hepatocyte, which is a marker of hepatic cell cancer, negative for AFP, and negative for PAS, which is a marker of mucinous carcinoma, thus disproving colon metastasis of hepatic cell cancer. hCG was negative and so there was no possibility of germinoma. Based on the above, the disease was diagnosed as low- Postoperatively the patient was discharged from the hospital 44 days after surgery without postoperative complications. He had orally been administered capecitabine 3,000 mg/day as adjuvant chemotherapy, but multiple lung metastases occurred bilaterally at 6 months after surgery. Chemotherapy of FOLFIRI+Bevacizumab was started and 8 cycles were conducted, but the effect was determined as PD, and the patient died on October 21, 2008.
Discussion
Carcinosarcoma of the colon is a malignant tumor composed of both carcinoma and sarcoma components. In the literature, carcinosarcoma occurring in the colon was first reported by Weidner and Zekan in 1986 [1] . To our knowledge, there have been reports of 19 cases to date (table 1). The mean age of patients was 69.1 years without any difference between males and females. No significant difference was observed in the ratio between carcinoma and sarcoma components. Lesions of carcinosarcoma were found in various places including the abdominal organs, skin, lung, mammary gland, eye, and head or neck, but its pathopoiesis remains unclear when compared with other malignant tumors. The mean survival period was as short as 6 months, showing extremely poor prognosis ( fig. 6) . The subject in this study was treated with positive chemotherapy upon occurrence of lung metastasis, but died 5 months later.
There are three histological theories: collision theory, composition theory, and combination theory. The combination theory has two subtheories: the metaplastic tumor theory which considers that the sarcoma component is secondarily derived from carcinoma, and the conversion tumor theory. With regard to carcinosarcomas which develop in the digestive system organs, the metaplastic theory is supported, which explains that in most cases, the carcinoma component precedes and that it is differentiated into the sarcomatoid component in accordance with the development of cancer clones [21] . A similar finding was reported for carcinosarcomas in the lung or bladder [22, 23] . Analyses of the inactivation pattern of X chromosome, P53, and LOH clarified that many patients with carcinosarcoma had combination tumor deriving from a single clone. A past report described that the epithelial component and sarcoma component of carcinosarcoma in the colon were classified into a weak positive sarcoma component, osteosarcomatoid component, and chondrosarcoma component without the former two components by staining cytokeratin using HE staining and immunostaining methods, and their prognoses were compared. Aramendi et al. [15] reported that there was heterologous differentiation in the osteo-and chondrosarcomatous areas and the prognosis of this group was uniformly dismal, and that in most cases, the timing of operation was correlated with its prognosis, and there was no case affecting the prognosis, though chemotherapy and radiotherapy were conducted after tumorectomy. In this patient, heterologous differentiation of osteo-and chondrosarcomatous areas was observed in the mesenchymal component. With regard to chemotherapy, 5-FU FL therapy (UFT+leucovorin), and capecitabine, or MMC, cisplatin have been administered to patients with metastasis in lymph nodes in accordance with colon cancer therapy, but a satisfactory treatment effect has not been obtained as yet [1, 6, 8, 12, 13, 18] . This patient had been orally administered capecitabine as postoperative adjuvant chemotherapy, but multiple lung metastases were observed by PET examination conducted 6 months after surgery. FOLFIRI (5-FU, l-LV, Irinotecan), which is the standard chemotherapy for progressive recurrent colon cancer, and Bevacizumab, which is a molecular target drug, were administered, but there was no treatment effect and metastatic lesions rapidly increased, and the patient died 10 months after surgery. Currently, the range of choice of therapeutic agents for progressive recurrent colon cancer has been spreading because of the emergence of molecular target drugs such as cetuximab, and therapeutic agents that are effective for carcinosarcoma are expected to become available on the market. this report meta = Metachronous; sync = synchronous; SC = sarcoma; Ca = carcinoma; S = sigmoid; D = descending; R = rectum; A = ascending; C = cecum; T = transverse. 
